Benoit COMBALUZIER
Inventor
Stats
- 1 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 7 US Applications Filed
- 28 Total Citation Count
- Jun 2, 2021 Most Recent Filing
- Jan 2, 2014 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
UNIVERSITAT ZURICH | 2
1 1 | 2014
2016 2017 |
NEURIMMUNE HOLDING AG | 2
1 1 | 2014
2016 2017 |
MABIMMUNE DIAGNOSTICS AG | 1
1 | 2016
2017 |
Inventor Addresses
Address | Duration |
---|---|
Schlieren, CH | Dec 14, 23 - Dec 14, 23 |
Urdorf, CH | Feb 25, 16 - Aug 03, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
C07K: | PEPTIDES | 7 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2023/0399,390 | 2023 | NOVEL ANTI-NOGO-A ANTIBODIES | 0 |
2023/0242,624 | 2023 | HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) | 1 |
2020/0071,390 | 2020 | RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES | 0 |
10450365 | 2019 | Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases | 1 |
2018/0037,635 | 2018 | RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES | 18 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.